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Static light scattering, small angle X-ray scattering and viscosity measure-
ments as a function of protein concentration are used to semi-quantitatively
correlate the oligomeric state of an IgG1 antibody (mAb1) with its rheolog-
ical behavior at solution pH 6.0 and varying ionic strength. Solution SAXS
coupled with optimized ensemble minimization was used to determine that
reversible mAb1 dimers form with extended structures in dilute solutions.
Light scattering measurements over a wide range of mAb1concentrations
(1- 175 mg/mL) provide detailed information on the equilibrium thermody-
namic interactions and their modulation by modest increases of ionic
strength. By applying interacting hard sphere models to fit the concentration
dependence of light scattering data, we observe the formation of equilibrium
protein clusters (depending on solution conditions) of 2- 8 mAb1 molecules.
Protein cluster size was found to be directly linked to concentrated IgG solu-
tion viscosities, which increased from 52 to 450 cP. Analysis of mAb1 solu-
tion viscosities as a function of ionic strength also established that effective
molecular sizes under constant sheer conditions increased with protein con-
centration. Collectively, the results reveal that the formation of elongated,
oligomeric structures increase mAb1 solution viscosities at high concentra-
tions, and suggest that only a small set of anisotropic interactions between
complimentary hydrophobic surfaces are required to nucleate and propagate
protein clusters.
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Intrinsically disordered proteins have very important flexible structures. In
order to analyze such proteins, we need new methodology for high-accuracy
measurements of three- dimensional (3D) intra-molecular motions. The struc-
ture of tau proteins in solution resembles that of a random coil. But, tau proteins
in Alzheimer paired helical filaments-like fibers have very little secondary
structures. Here, we observed the 3D structural motions of tau proteins using
Diffracted X-ray Tracking (DXT) as high-speed x-ray single molecule obser-
vations. In DXT, we observed Brownian motions of recombinant tau proteins
and his-tagged tau proteins, which are adsorbed on the substrate’s surface.
These adsorbed tau proteins was reacted to many antibodies and was phosphor-
ylated by several kinases. We succeeded in measuring three-dimensional
(3D= 2 axes as polar coordinates) micro-second super-high accuracy (pico-
meter scale) motion maps of individual single molecule observations at
many conditions of the tau proteins. From dynamic DXT data, for example,
the tau protein combined with the antibody was confirmed that structure fluc-
tuation had become slightly large compared with that which is not combined.
We discuss the aggregation process of tau protein from these dynamic intra-
molecular data under many conditions.
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Self-assembling amphiphilic designer-peptides are used as building blocks for
the development of controllable, tailor-made biomaterials. In solution, they
self-assemble above a critical aggregation concentration into supramolecular
structures, like vesicles, bilayers, twisted tapes, fibers or tubes. In this study
we investigated the concentration- and time-dependent self-assembly of an
8-residue amphiphilic designer-peptide. We observed structural transitions
from peptide monomers to elongated pairwise aligned tapes. Highly concen-
trated samples assembled into the first double helix superstructure that was
observed within the class of amphiphilic designer-peptides so far. Synchrotronsmall angle X-ray scattering provided a detailed insight into the internal
organization of the double helix. The obtained electron-density-profile sug-
gested a 3-shell-model, mirrored at the central axis. Shell 1 (~1 nm) and shell
2 (~3.5 nm) together account for the peptide containing region, where the hy-
drophobic parts of the peptide monomers were interdigitated and tightly
packed. In the innermost region we confirmed antiparallel stacking due to inter-
molecular hydrogen bonding by circular dichroism and infrared spectroscopy.
Shell 3 spans around 12 nm and was assigned to a hydration shell where
negatively charged trifluoroacetate counter ions preferably attach to the posi-
tively charged peptide headgroups. The total diameter of the double helix
was 24 nm, with a repeating pitch distance of ~60 nm. Cryo transmission elec-
tron microscopy supported the double helix morphology and revealed that their
lengths extended to several hundreds of nanometers. The double helices were
intertwined into a tight network. The resulting hydrogel properties may lead
to promising future applications.
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Systemic light chain amyloidosis (AL amyloidosis) is a rare but fatal sys-
temic amyloid disease. It usually strikes in the wake of myeloma, a form
of cancer that affects plasma cells in the adaptive immune system. During
plasma cell development from primary B cells, the immunoglobulin light
chain (LC) genes undergo several rearrangements that leave each cell with
a unique version of the protein. In myelomas one plasma cell clone rapidly
reproduces itself. Instead of fulfilling their former immunological role, the
LCs cluster into amyloid. A similar process underlies the Multiple Myeloma
(MM) pathology, but here the protein does not go on to form amyloid. Our
study aims to understand the biophysical basis of this difference between
AL and MM.
In both diseases large amounts of soluble LC are secreted into circulation and
excreted with urine. Hence we hypothesize that amyloid deposition depends
on the amyloid formation propensity of the individual LC sequences rather
than being a result of different LC concentrations being present in both dis-
eases. To test this hypothesis we used a simple purification strategy to isolate
LC from urine of patients suffering from the two diseases, excluding cases
where renal failure was indicated. We then recorded aggregation kinetics at
multiple concentrations in vitro to quantify the stabilities and aggregation pro-
pensities of the individual LC proteins. We found that LC protein from AL
and MM patients both formed amyloid fibrils at comparable concentrations,
but with different aggregation rates, suggesting that amyloid formation may
be kinetically inhibited in MM patients. We will now expand the study to a
larger group of patients and derive LC sequences from bone marrow. We
hope to establish a correlation between specific differences in sequences
and clinical parameters in AL and MM, which could enable a more personal-
ized treatment of patients.
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Aggregation is a major challenge in the development of antibody-based ther-
apeutics. Therapeutic antibodies are produced and stored in high concentra-
tions and generated under varying and unfavourable conditions for the
stability of monomeric proteins. The aggregation of these proteins in solution
can lead to serious consequences for patients in the form of the initiation of
immune reactions, which have the potential to be fatal, and in the loss of
clinical potency. Further to this, the type of aggregates formed by antibodies,
and the processes that lead to their propagation, are relatively poorly under-
stood. Thus by investigating these molecules as a model system we may
find out more about other, more complex systems known to involve aggrega-
tion - including amyloids. Here we apply multiscale molecular dynamics
simulations to investigate the aggregation of antibody fragments. Using
coarse-grained molecular dynamics (CG-MD) we are able to access much
longer timescales than traditional atomistic methodologies, and to look at
much larger ensembles of proteins. We are also able to glycosylate these
models, and convert structures back to atomistic detail. CG simulations of
systems containing 2 protein fragments give us insights into the specific in-
teractions and, which surfaces on the molecular structures are involved in
them. Simulations of much larger ensembles of proteins (from 4 and up to
16 antibody fragments) allow us to look the formation of larger aggregates,
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ments. Combining all these molecular dynamics methodologies we are able
to gain insights into the most likely interactions between proteins, and on the
most likely method of aggregation, and the potential structures of protein
aggregates.
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Many proteins form ordered structural aggregates called amyloid fibrils,
which are associated with numerous neurodegenerative diseases. Insulin, a
largely a-helical protein, undergoes conformational changes under certain
stress conditions leading to amyloid fibrils. Fibrillation of insulin poses a
problem in its long-term storage, reducing its efficacy in treating type II dia-
betes. Oligomeric dissociation of insulin into its monomer is the key step for
the onset of fibrillation. In the present study, we have used a non-toxic nine
residue peptide, NK9 (NIVNVSLVK) constituting mostly with hydrophobic
residues, which interferes fibrillation of insulin. The time course of insulin
fibrillation at 62C using Thioflavin T fluorescence shows an increase in
the lag time from 120 min without peptide to 236 min with peptide. TEM
micrographs show branched insulin fibrils in its absence and less inter-fibril
association in its presence. FTIR study shows, loss of a-helical structure of
insulin upon incubation, but if the peptide is added, secondary structure is
almost fully maintained for 3 h, though lost partially at 4 h. Size exclusion
chromatography study confirms the resistance of the peptide towards the olig-
omeric dissociation of insulin into its monomer in the course of fibrillation.
Saturation transfer difference (STD) NMR was used to confirm the binding
epitope of NK9, where the hydrophobic residues give signal of resonance
transfer being in close contact with insulin. MD simulation in conjunction
with PCA analysis reveals how the binding of NK9 governs the interruption
of insulin fibrillation. An estimation of probable aggregation site of insulin
gives a clue for NK9 activity. The present study is considered to be helpful
for architecting new peptide based leads for efficient stopping of aggregation
of insulin.
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Kinetic studies of protein aggregation processes based on the nucleation-
polymerization (NP) mechanism and/or its variants are often formulated in
terms of the law of mass action. Although these works have greatly
enhanced our knowledge in the microscopic descriptions of fibril/aggregate
formation (e.g., fragmentation and other secondary pathways), they have to
inevitably deal with a huge number of filament species Fn (n=1 to 10^3 ~
10^4 or even more) as well as a number of kinetic parameters. Very often
some kinetic assumptions for the species with a wide distribution of sizes
and shapes would be needed in order to simplify the calculation. In contrast,
starting from a phase-transition perspective, one is able to provide thermo-
dynamic insight into the nucleation-controlled kinetic behavior. In this
work, we propose to apply the kinetic Ising model to investigate the thermo-
dynamics and kinetics of protein aggregation. At mean-field (MF) level, our
model can offer thermodynamic interpretation to the lag time; in particular,
it can explain the effect of temperature, concentration, and seeding on the
change of kinetic profiles. Using four real proteins as examples, we show
that the calculated fibril stability is consistent with experimental measure-
ments. In addition, their kinetics can be classified according to a generalized
scheme of the model. Our results suggest that protein aggregation could be
studied within the framework of the Ginzberg-Landau phase transition
theory.
321-Pos Board B76
Proteome Metastability in Health, Aging, and Disease
Prajwal Ciryam1,2, Gian G. Tartaglia3, Richard I. Morimoto2,
Christopher M. Dobson1, Edward P. O’Brien4, Michele Vendruscolo1.
1Department of Chemistry, University of Cambridge, Cambridge, United
Kingdom, 2Department of Molecular Biosciences, Northwestern University,
Evanston, IL, USA, 3Center for Genomic Resolution, Barcelona, Spain,
4Department of Chemistry, Pennsylvania State University, University Park,
PA, USA.
Maintaining protein solubility is fundamental to proteostasis, as the formation
of diverse aggregated species is associated with a variety of cytotoxic eventsand disorders, including Alzheimer’s and Parkinson’s diseases. Increasing ev-
idence indicates that protein aggregation can be widespread in living systems,
as many different proteins aggregate upon cellular stress. The origins of this
proteomic metastability, however, remain unclear, as do the reasons only
certain proteins aggregate in vivo. We have applied simple models of cotransla-
tional folding and protein supersaturation to quantify metastability at a prote-
ome scale. We find that many proteins can shift from cotranslational to
posttranslational folding because of translation kinetics, a source of metasta-
bility for nascent chains. Further, we show that the proteins most vulnerable
to aggregation are those whose cellular
concentrations are high relative to their
intrinsic solubilities. These supersaturated
proteins constitute a metastable sub-
proteome involved in forming pathological
assemblies in stress and ageing. We find
that such proteins are overrepresented in
the biochemical processes associated with
neurodegenerative disorders, helping to
rationalise their specific cellular pathol-
ogies. We anticipate that this type of anal-
ysis can provide a generally applicable
basis for tracking the instability of pro-
teomes in ageing, stress, and disease.322-Pos Board B77
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As part of the protein quality control centre of the cell, many molecular chap-
erones tightly regulate amyloid proteins and seem to play an important role
in neurodegeneration. However, the precise mechanism of this interplay and
how its modification leads to disease remains elusive. Particularly oligomeric
species of amyloid proteins have emerged as the most important mediators of
neurotoxicity in neurodegenerative diseases. These amyloid species are
exceedingly hard to characterize as they are transient, heterogeneous and
rare relative to the monomeric and fibrillar states. Single-molecule fluores-
cence spectroscopy allows us to specifically characterise the oligomeric
species and follow their structural development during fibril formation and
dissociation. We employed this technique to characterise the oligomers
evolving during the aggregation of a recombinant tau variant carrying the
D280K mutation associated with some forms of frontotemporal dementia.
Further, we studied the in vitro interaction of these oligomers with the chap-
erone Hsp70 which has previously been identified as a key regulator of tau
turnover in the cell. We found that Hsp70 controls the oligomerisation
and fibrillisation of tau interacting more strongly with oligomers of a
certain size and structure. Our results provide insights into the molecular
mechanism by which Hsp70 inhibits tau aggregation and targets oligomers
for degradation.
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In the tragic event of an injury, the body’s main mechanism to hinder blood loss
is to form a thrombus. This process primarily consists of the conversion of
fibrinogen to fibrin through an enzymatic reaction catalyzed by thrombin.
The fibrin network’s structure is dependent on the concentration of thrombin
present as well as on environmental conditions during network formation.
Here we present how thrombin concentration and flow conditions affect the for-
mation of fibrin in a controlled environment. Fibrin networks are grown in a
microfluidic device and their porosity is determined using conductance mea-
surements in the presence of macroions of various sizes. The porosity of fibrin
is relevant to its biological role influencing the outcome in the wound healing
process.
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Biological function relies on biochemical reactions that require spatial prox-
imity between biomolecules. We are investigating how DNA segregation and
